Related Experiment Video

Updated: Oct 30, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.8K

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs

Alessandro Prete1, Antonio Matrone1, Carla Gambale1

  • 1Endocrine Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Via Paradisa 2, 56124 Pisa, Italy.

Cancers
|July 2, 2021
PubMed

Insights

Poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) have poor survival rates. New research explores their genetic features and tumor microenvironments to improve treatment strategies for these rare but aggressive thyroid cancers.

Area of Science:

  • Oncology
  • Genetics
  • Cancer Biology

Background:

  • Poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) are rare but aggressive thyroid malignancies.
  • These cancers are associated with poor overall survival and limited efficacy of conventional therapies.
  • Understanding the underlying genetic landscape and tumor microenvironment is crucial for therapeutic advancements.

Purpose of the Study:

  • To review recent findings on the genetic alterations (DNA and RNA) in PDTC and ATC.
  • To describe the immune and non-immune tumor microenvironments of PDTC and ATC.
  • To summarize how emerging evidence is influencing the treatment paradigms for PDTC and ATC.

Main Methods:

  • Comprehensive literature review of recent studies on PDTC and ATC.
  • Analysis of genetic mutations and RNA alterations.
  • Examination of tumor microenvironment components and cell interactions.

Main Results:

  • PDTC and ATC exhibit distinct genetic profiles and complex tumor microenvironments.
  • Interactions between tumor cells and their microenvironment significantly impact disease progression.
  • Current therapeutic strategies are being re-evaluated based on these novel insights.

Conclusions:

  • Advances in understanding the molecular and cellular biology of PDTC and ATC are critical.
  • Targeted therapies and immunotherapies hold promise for improving patient outcomes.
  • Personalized treatment approaches are essential for managing these challenging thyroid cancers.
Keywords:
anaplastic thyroid cancergenetic landscapegenetically guided therapypoorly thyroid cancertumor microenvironment

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.6K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K